Skip to content

Azosemide

Drug profile

Also known as: azosemid, diurapid

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Azosemide is a drug catalogued in DrugCentral. Recorded indications include Congestive heart failure.

  • Indications: Congestive heart failure.
  • Molecular formula: C12H11ClN6O2S2; molecular weight 370.83 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Congestive heart failure

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA termLLR
Cardiac failure802.3
Renal impairment512.6
Cardiac failure chronic357.2
Blood pressure decreased202.3
Cerebral infarction194.9
Hepatic function abnormal192.5
Dehydration150.0
Brain natriuretic peptide increased147.3
Concomitant disease aggravated140.8
Pulmonary arterial hypertension134.3
Cardiac failure acute130.8
Hyperkalaemia115.7

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Azosemide is on its molecule page.

Molecular formulaC12H11ClN6O2S2
Molecular weight370.83 g/mol
CAS number27589-33-9
InChIKeyHMEDEBAJARCKCT-UHFFFAOYSA-N
PubChem CID2273
NS(=O)(=O)C1=CC(C2=NN=NN2)=C(NCC2=CC=CS2)C=C1Cl

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Azosemide used for?

DrugCentral lists the following indications for Azosemide: Congestive heart failure.

What is the chemical formula of Azosemide?

Azosemide has the molecular formula C12H11ClN6O2S2 and a molecular weight of 370.83 g/mol.

Browse: all drugs starting with A · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
Agency—
Targets0
Indications1
FormulaC12H11ClN6O2S2
DrugCentral ID278
Interactive profile